Nanoplasmas is Biotechnology in Greece that focus on patented technology business. Founded in 2016. They cover business area such as developer, nanotechnology, diagnostic, life science, a method, surface, plasma processing, bioanalytic microdevice, chip, microarray, microfluidic, researcher, optimize performance, Legionella pheumophila bacteria, water.
2016
( 8 years old in 2024 )
Patented Technology
-
TEPA Lefkippos, Patriarchou Grigoriou & Neapoleos 27
PO Box 60037, Agia Paraskevi
Attiki, 153 41
Greece
Private
developernanotechnologydiagnosticlife sciencea methodsurfaceplasma processingbioanalytic microdevicechipmicroarraymicrofluidicresearcheroptimize performanceLegionella pheumophila bacteriawater
* We use standard office opening hours in near Nanoplasmas's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Nanoplasmas is Biotechnology business from Greece that founded in 2016 (8 years old in 2024), Nanoplasmas business is focusing on Patented Technology.
Nanoplasmas headquarter office and corporate office address is located in TEPA Lefkippos, Patriarchou Grigoriou & Neapoleos 27 PO Box 60037, Agia Paraskevi Attiki, 153 41 Greece.
Nanoplasmas was founded in Greece.
In 2024, Nanoplasmas is currently focus on patented technology sector.
Above is snippet of Google Trends for "patented technology" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Nanoplasmas, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
